Gregory P. Licholai
Lecturer, Yale School of Management; Chief Medical and Chief Innovation Officer, ICON plc
Contact
Greg teaches Sustainable Innovation in Healthcare: Managing Continuous Improvements in Developing Products and Services. He is also Chief Medical and Chief Innovation Officer at ICON plc, a leading pharmaceutical service, healthcare data and contract research firm. Previously, he was President of Rare Disease at Moderna Therapeutics, and had leadership roles at McKinsey & Co., Quintiles, Amicus Therapeutics, Domain Associates and Medtronic Neurological. He is co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University, and Boston College. He trained in neurosurgery at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He is on several healthcare company boards and medical advisory boards. Greg writes about innovation for Forbes.
Education
- MBA, Harvard University, 2000
- MD, Yale University School of Medicine, 1995
Selected Works
Articles
- Digital Healthcare Growth Drivers In 2020
G. Licholai
Forbes
Volume January 14, 2020
- Johnson & Johnson, Apple’s New Virtual Trial Model Shows Early Enrollment Success
G. Licholai
Forbes
Volume March 9, 2020
Selected Books
- Introduction to Medical Software: Foundations for Digital Health, Devices, and Diagnostics
G. P. Licholai, X. Papademetris, and A. N. Quraishi
2022
Yale SOM Case Studies
- Population Health Management at Atrius
Yale School of Management Case Study
2016
- Nomad Health and the Disruption of Physician Staffing Services
Yale School of Management Case Study
2017
- Cobalt and the Rise of Digital Health
Yale School of Management Case Study
2018
- Everlywell and Creating Access to Lab Testing
Yale School of Management Case Study
2019
- Talkspace and digital health market dynamics
Yale School of Management Case Study
2019
- Medical Tourism, Neurosurgery and Singapore’s Largest Health System
Yale School of Management Case Study
2018
- CRISPR Therapeutics and Editing the Human Genome
Yale School of Management Case Study
2018
- The Health Data Insurgency
Yale School of Management Case Study
2020